Utilization of NIR Spectroscopy in Candesartan Cilexetil Stability Study

被引：0

作者：

Dohnal, Jiri ^{[1
,2
]}

Jampilek, Josef ^{[1
,2
]}

Oktabec, Zbynek ^{[2
]}

Zerzanova, Anna ^{[1
]}

Kral, Vladimir ^{[1
,3
]}

机构：

[1] Zentiva AS, U Kabelovny 130, Prague 10237 10, Czech Republic

[2] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Chem Drugs, Brno 61242, Czech Republic

[3] Inst Chem Technol, Fac Chem Engn, Dept Analyt Chem, Prague 16628 6, Czech Republic

来源：

2009 34TH INTERNATIONAL CONFERENCE ON INFRARED, MILLIMETER, AND TERAHERTZ WAVES, VOLS 1 AND 2 | 2009年

关键词：

NEAR-INFRARED SPECTROSCOPY;

D O I：

暂无

中图分类号：

TM [电工技术]; TN [电子技术、通信技术];

学科分类号：

0808 ; 0809 ;

摘要：

For formulation of candesartan cilexetil and for its stabilization in dosage form was used the coating/complexation by macrogol. NIR spectrometry was utilized for analysis of development samples to optimize ratios candesartan cilexetil and macrogol. The stable dosage form was developed by means of the NIR spectrometry.

引用

页码：317 / 317

页数：1

共 50 条

[1] Candesartan cilexetil
不详
DRUGS OF THE FUTURE, 2002, 27 (01) : 70 - 70
[2] A stability-indicating LC method for candesartan cilexetil
Rao, D. V. Subba
Radhakrishnanand, P.
Suranarayana, M. V.
Himabindu, V.
CHROMATOGRAPHIA, 2007, 66 (7-8) : 499 - 507
[3] A Stability-Indicating LC Method for Candesartan Cilexetil
D. V. Subba Rao
P. Radhakrishnanand
M. V. Suryanarayana
V. Himabindu
Chromatographia, 2007, 66 : 499 - 507
[4] In vitro hydrolysis of candesartan cilexetil to candesartan
Miwa, K
Murakami, H
Masaki, K
Iwasaki, M
Yoshimura, Y
Motohashi, M
JOURNAL OF HYPERTENSION, 1998, 16 : S130 - S130
[5] Candesartan cilexetil: an update
Joost, Alexander
Schunkert, Heribert
Radke, Peter Walter
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (11) : 1769 - 1780
[6] AstraZeneca launches candesartan cilexetil
不详
SOUTH AFRICAN MEDICAL JOURNAL, 1999, 89 : C226 - C226
[7] PREFORMULATION STUDY FOR CANDESARTAN CILEXETIL BUCCAL (EFFERVESCENT) TABLET
Pansuriya, K.
Shelat, P.
Patel, H.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (06): : 2868 - 2874
[8] Candesartan cilexetil vs losartan
OK Andersson
S Neldam
Journal of Human Hypertension, 1998, 12 : 419 - 420
[9] Candesartan cilexetil in cardiovascular prevention
Ivleva, A. Ya.
CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (06): : 83 - 90
[10] No cardiotoxicity protection with candesartan cilexetil
Reactions Weekly, 2016, 1608 (1) : 6 - 6

← 1 2 3 4 5 →